The FDA is requiring all GLP-1 weight-loss and diabetes drugs, including Ozempic and Wegovy, to carry a warning for a rare condition linked to permanent vision loss.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The FDA is requiring all GLP-1 weight-loss and diabetes drugs, including Ozempic and Wegovy, to carry a warning for a rare condition linked to permanent vision loss.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
